L. E. Robertson

Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy

Michael J. Keating, Susan O’Brien, Susan Lerner et al. · Blood · 1998 · 422 citations

Medicine, Oncology, Chemotherapy +10

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

Elihu H. Estey, Peter F. Thall, Michael Andreeff et al. · Journal of Clinical Oncology · 1994 · 297 citations

Medicine, Hematology, Pharmacotherapy +17

Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome.

L. E. Robertson, William Plunkett, Kristina McConnell et al. · PubMed · 1996 · 291 citations

Life Sciences, Hematology, Oncology +12

Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]

S O'Brien, Hagop M. Kantarjian, Miloslav Beran et al. · Blood · 1993 · 280 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Induction of apoptotic cell death in chronic lymphocytic leukemia by 2- chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine

L. E. Robertson, Sherri Chubb, RE Meyn et al. · Blood · 1993 · 275 citations · Full text

Life Sciences, Cell Biology, Oncology +14